Expert Opinion on Pharmacotherapy
Volume 24, 2023 - Issue 7
366
Views
0
CrossRef citations to date
0
Altmetric
Special Report
The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma
Samantha M. Ruffa Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States of AmericaView further author information
, Sameek Roychowdhuryb Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States of AmericaView further author information
& Timothy M. Pawlika Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States of AmericaCorrespondence[email protected]
View further author information
View further author information
|
Related Research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.